Tatiana I. Netzeva

Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships

Tatiana I. Netzeva, Andrew Worth, Tom Aldenberg et al. · Alternatives to Laboratory Animals · 2005 · 814 citations

Pharmacy, Pharmacology, Drug Design +9

Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization

Katie Paul Friedman, Matthew Gagné, Lit‐Hsin Loo et al. · Toxicological Sciences · 2019 · 245 citations · Full text

Pharmacy, Toxicology, Environmental Toxicology +16

The Benigni / Bossa rulebase for mutagenicity and carcinogenicity - a module of Toxtree

Romualdo Benigni, Cecilia Bossa, Nina Jeliazkova et al. · 2008 · 176 citations

Pharmacy, Bioinformatics, Toxicology +15

Comparative assessment of methods to develop QSARs for the prediction of the toxicity of phenols to Tetrahymena pyriformis

M Cronin, Aynur O. Aptula, Judith Duffy et al. · Chemosphere · 2002 · 160 citations

Pharmacy, Toxicology, Drug Discovery +8

The role of the European Chemicals Bureau in promoting the regulatory use of (Q)SAR methods

Andrew Worth, Arianna Bassan, Jack de Bruijn et al. · SAR and QSAR in environmental research · 2007 · 147 citations

Pharmacy, Environmental Sciences, Toxicology +17